home / stock / gmab / gmab news


GMAB News and Press, Genmab A/S From 11/27/23

Stock Information

Company Name: Genmab A/S
Stock Symbol: GMAB
Market: NYSE
Website: genmab.com

Menu

GMAB GMAB Quote GMAB Short GMAB News GMAB Articles GMAB Message Board
Get GMAB Alerts

News, Short Squeeze, Breakout and More Instantly...

GMAB - AbbVie-Genmab lymphoma drug gets FDA breakthrough designation

2023-11-27 08:03:06 ET More on AbbVie, Genmab, etc. AbbVie Vs. Amgen: How Peter Lynch Picks Dividend Stocks Genmab A/S (GMAB) Q3 2023 Earnings Call Transcript Genmab A/S 2023 Q3 - Results - Earnings Call Presentation AbbVie suing Sandoz, four others to block ...

GMAB - Genmab Announces Positive Regulatory Updates for Epcoritamab (EPKINLY®/TEPKINLY®) for the Treatment of Relapsed/Refractory Follicular Lymphoma

U.S. Food and Drug Administration (FDA) grants Breakthrough Therapy Designation (BTD) for epcoritamab-bysp for the treatment of relapsed or refractory (R/R) follicular lymphoma (FL) after two or more lines of systemic therapy European Medicines Agency (EMA) validates regulatory applicatio...

GMAB - Major Shareholder Announcement

Company Announcement Major shareholder announcement for Genmab A/S COPENHAGEN, Denmark; November 8, 2023 – Genmab A/S (Nasdaq: GMAB) announces under reference to Section 30 of the Danish Capital Markets Act that Wellington Management Group LLP has inform...

GMAB - Genmab reports 9M results

2023-11-07 17:19:08 ET More on Genmab Genmab A/S (GMAB) Q3 2023 Earnings Call Transcript Genmab A/S 2023 Q3 - Results - Earnings Call Presentation Genmab Is Down To Attractive Levels Seagen, Genmab update Phase 3 data for uterine cancer therapy Genmab...

GMAB - Genmab A/S (GMAB) Q3 2023 Earnings Call Transcript

2023-11-07 14:32:09 ET Genmab A/S (GMAB) Q3 2023 Earnings Conference Call November 07, 2023 12:00 PM ET Company Participants Jan van de Winkel - Co-Founder, President & Chief Executive Officer Anthony Pagano - Executive Vice President & Chief Financial Office...

GMAB - Genmab Announces Financial Results for the First Nine Months of 2023

November 7, 2023 Copenhagen, Denmark; Interim Report for the First Nine Months Ended September 30, 2023 Highlights Epcoritamab (TEPKINLY ® ) was granted conditional marketing authorization by the European Commission (EC) to treat adults with relapsed or re...

GMAB - Expected US Company Earnings on Tuesday, November 7th, 2023

Weyco Group Inc. (WEYS) is expected to report for Q1 2024 Gladstone Land Corporation (LAND) is expected to report $0.16 for Q3 2023 PlayAGS Inc. (AGS) is expected to report $0.01 for Q3 2023 Ardmore Shipping Corporation (ASC) is expected to report $0.43 for Q3 2023 Sage Therapeuti...

GMAB - Expected earnings - Genmab A/S

Genmab A/S (GMAB) is expected to report $0.34 for Q3 2023

GMAB - Notable earnings before Tuesday's open

2023-11-06 10:30:08 ET Major earnings expected before the bell on Tuesday include: Air Products and Chemicals ( APD ) Datadog ( DDOG ) D.R. Horton ( DHI ) Emerson Electric ( EMR ) Uber Technologies ( UBER ) For further details see: Notable...

GMAB - Genmab Announces Multiple Abstracts to be Presented at the 65th Annual Meeting and Exposition of the American Society of Hematology (ASH)

Eighteen total abstracts accepted for presentation and publication, including results from four clinical trials evaluating epcoritamab in multiple treatment settings and patient populations Oral presentations highlighting new findings from a clinical trial of epcoritamab in patients with ...

Previous 10 Next 10